Back to Search Start Over

A spinal cord neuroprosthesis for locomotor deficits due to Parkinson's disease.

Authors :
Milekovic T
Moraud EM
Macellari N
Moerman C
Raschellà F
Sun S
Perich MG
Varescon C
Demesmaeker R
Bruel A
Bole-Feysot LN
Schiavone G
Pirondini E
YunLong C
Hao L
Galvez A
Hernandez-Charpak SD
Dumont G
Ravier J
Le Goff-Mignardot CG
Mignardot JB
Carparelli G
Harte C
Hankov N
Aureli V
Watrin A
Lambert H
Borton D
Laurens J
Vollenweider I
Borgognon S
Bourre F
Goillandeau M
Ko WKD
Petit L
Li Q
Buschman R
Buse N
Yaroshinsky M
Ledoux JB
Becce F
Jimenez MC
Bally JF
Denison T
Guehl D
Ijspeert A
Capogrosso M
Squair JW
Asboth L
Starr PA
Wang DD
Lacour SP
Micera S
Qin C
Bloch J
Bezard E
Courtine G
Source :
Nature medicine [Nat Med] 2023 Nov; Vol. 29 (11), pp. 2854-2865. Date of Electronic Publication: 2023 Nov 06.
Publication Year :
2023

Abstract

People with late-stage Parkinson's disease (PD) often suffer from debilitating locomotor deficits that are resistant to currently available therapies. To alleviate these deficits, we developed a neuroprosthesis operating in closed loop that targets the dorsal root entry zones innervating lumbosacral segments to reproduce the natural spatiotemporal activation of the lumbosacral spinal cord during walking. We first developed this neuroprosthesis in a non-human primate model that replicates locomotor deficits due to PD. This neuroprosthesis not only alleviated locomotor deficits but also restored skilled walking in this model. We then implanted the neuroprosthesis in a 62-year-old male with a 30-year history of PD who presented with severe gait impairments and frequent falls that were medically refractory to currently available therapies. We found that the neuroprosthesis interacted synergistically with deep brain stimulation of the subthalamic nucleus and dopaminergic replacement therapies to alleviate asymmetry and promote longer steps, improve balance and reduce freezing of gait. This neuroprosthesis opens new perspectives to reduce the severity of locomotor deficits in people with PD.<br /> (© 2023. The Author(s), under exclusive licence to Springer Nature America, Inc.)

Details

Language :
English
ISSN :
1546-170X
Volume :
29
Issue :
11
Database :
MEDLINE
Journal :
Nature medicine
Publication Type :
Academic Journal
Accession number :
37932548
Full Text :
https://doi.org/10.1038/s41591-023-02584-1